Modern Healthcare News
 
RSS feed

Genetic testing news and information

Vital Signs
Macquarie analysis finds increased interest in DNA sequencing
By Darius Tahir | July 24, 2014
Healthcare organizations plan to ramp up their spending on DNA sequencing, though generally not on the sequencers themselves, according to a survey by Macquarie Research, the research arm of the investment bank Macquarie Group.
FULL STORY »
 

Vital Signs
FDA: We like innovation. Just don't mess it up
By Darius Tahir | June 27, 2014
After an appearance before the U.S. House Energy & Commerce Committee, Dr. Jeffrey Shuren, director of the Food and Drug Administration's Center for Devices and Radiological Health, decided he should issue another communiqué clarifying his agency's position on innovation—this time on...
FULL STORY »
 

Information
As sequencing moves into clinical use, insurers balk
By Reuters | June 20, 2014
Once strictly the domain of research labs, gene-sequencing tests increasingly are being used to help understand the genetic causes of rare disease, putting insurance companies in the position of deciding whether to pay the $5,000 to $17,000 for the tests.
FULL STORY »
 

News
Genetic cancer screening moves beyond single-gene tests
By Jaimy Lee | May 22, 2014 | Basic Web Basic Web Subscription Details
Clinicians are ordering more comprehensive gene tests to look for mutations carrying higher risks of hereditary cancer.
FULL STORY »
 

News
Genome-analysis firm Omicia names Billings medical chief
By Rachel Landen | May 12, 2014 | Basic Web Basic Web Subscription Details
Dr. Paul Billings is the new chief medical officer of Omicia, an Oakland, Calif.-based company that provides genome analysis technology for research, diagnostic and clinical applications.
FULL STORY »
 


Advertisement | View Media Kit

News
Myriad feels impact of Medicare reimbursement cuts
By Jaimy Lee | May 06, 2014 | Basic Web Basic Web Subscription Details
Myriad Genetics reported double-digit revenue growth in the third quarter even as sales in its oncology business dropped following cuts in Medicare reimbursement for hereditary breast and ovarian cancer testing.
FULL STORY »
 

Magazine
Outliers: FDA angling to catch finny fraud
By Modern Healthcare | May 03, 2014 | Print Magazine Print Magazine Subscription Details
The Food and Drug Administration thinks Americans could be falling for some pretty big fish stories, so it's getting to the bottom of the deception at the DNA level.
FULL STORY »
 

News
FDA approves DNA-based HPV test over women's groups' protest
By Sabriya Rice | April 24, 2014 | Basic Web Basic Web Subscription Details
The first human papillomavirus DNA test to screen women for cervical cancer was approved Thursday by the U.S. Food and Drug Administration. The stand-alone test can be used to assess whether women need to undergo additional testing and their risk of developing cervical cancer in the future.
FULL STORY »
 

News
Colorado center will offer treatments targeted by patient DNA
By Andis Robeznieks | April 21, 2014 | Basic Web Basic Web Subscription Details
Four Colorado healthcare organizations planning a $63 million Center for Personalized Medicine aim to use patients' DNA to predict their risk of disease and develop targeted treatments based on the genetic information.
FULL STORY »
 

Information
Enlisting a computer to battle cancers, one by one
By New York Times | March 28, 2014
When Robert B. Darnell was a graduate student in the early 1980s, he spent a year sequencing a tiny fragment of DNA. Now Dr. Darnell is an oncologist and the president of the New York Genome Center, where the DNA-sequencing machines can decode his grad-school fragment in less than a ten-thousandth...
FULL STORY »
 

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.